# FDA 483 - Cassie L. Blanchard, PhD - June 13, 2023

Source: https://www.keypedia.com/records/483/cassie-l-blanchard-phd/2920d5f2-18c9-4c73-9119-02503ed37749

> FDA 483 for Cassie L. Blanchard, PhD on June 13, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Cassie L. Blanchard, PhD
- Inspection Date: 2023-06-13
- Product Type: drugs
- Office Name: New Jersey District Office
- Summary: An FDA inspection of Cassie L. Blanchard, PhD, a clinical investigator in Berlin, NJ, revealed significant deviations from investigational plans and inadequate record-keeping. Observations included failures to conduct subject assessments according to protocol and a lack of contemporaneous completion or source records for case histories. These findings indicate serious concerns regarding the integrity and conduct of clinical studies.

## Related Officers

- [investigator](https://www.keypedia.com/people/tyanna-n-hadley/8fdebfd7-d6f3-44ab-9dcb-864ab6d55d53)

Company: https://www.keypedia.com/companies/cassie-l-blanchard-phd/257b891d-759b-432c-ae28-b829aab26940

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248